Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
1,385,160,313
-
Number of holders
-
198
-
Total 13F shares, excl. options
-
49,117,793
-
Shares change
-
+910,618
-
Total reported value, excl. options
-
$9,252,708,810
-
Value change
-
+$179,007,715
-
Put/Call ratio
-
37%
-
Number of buys
-
111
-
Number of sells
-
81
-
Price
-
$188.40
Institutional Holders of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) as of Q2 2020
As of 30 Jun 2020 BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC) had 198 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 49,117,793 shares of stock of the company.
Largest 10 holders included BAKER BROS. ADVISORS LP, Capital International Investors, HILLHOUSE CAPITAL ADVISORS, LTD., FMR LLC, Temasek Holdings (Private) Ltd, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, PRIMECAP MANAGEMENT CO/CA/, CAPITAL INTERNATIONAL INC, and BOXER CAPITAL, LLC.
This table shows 201 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.